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SNAKEBITES BY Crotalus durissus ssp IN CHILDREN IN CAMPINAS, SÃO PAULO, BRAZIL
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SUMMARY
From January, 1984 to March, 1999, 31 children under 15 y old (ages 1-14 y, median 8 y) were admitted after being bitten by
rattlesnakes (Crotalus durissus ssp). One patient was classified as “dry-bite”, 3 as mild envenoming, 9 as moderate envenoming and
18 as severe envenoming. Most patients had neuromuscular manifestations, such as palpebral ptosis (27/31), myalgia (23/31) and
weakness (20/31). Laboratory tests suggesting rhabdomyolysis included an increase in total blood creatine kinase (CK, 28/29) and
lactate dehydrogenase (LDH, 25/25) levels and myoglobinuria (14/15). The main local signs and symptoms were slight edema (20/
31) and erythema (19/31). Before antivenom (AV) administration, blood coagulation disorders were observed in 20/25 children that
received AV only at our hospital (incoagulable blood in 17/25). AV early reactions were observed in 20 of these 25 cases (9/9 patients
not pretreated and 11/16 patients pretreated with hydrocortisone and histamine H1 and H2 antagonists). There were no significant
differences in the frequency of patients with AV early reactions between the groups that were and were not pretreated (Fisher’s exact
test, p = 0.12). Patients admitted less than and more than 6 h after the bite showed the same risk of developing severe envenoming
(Fisher’s exact test, p = 1). No children of the first group (< 6 h) showed severe complications whereas 3/6 children admitted more
than 6 h post-bite developed acute renal failure. Patients bitten in the legs had a higher risk of developing severe envenoming (Fisher’s
exact test, p = 0.04). There was a significant association between both total CK and LDH blood enzyme levels and severity (p < 0.001
for CK and p < 0.001 for LDH; Mann-Whitney U test). No deaths were recorded.
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INTRODUCTION
The South American rattlesnake (Crotalus durissus ssp) is one of
the most dangerous venomous snakes of Brazil5,8. According to the
Brazilian Ministry of Health, from 1990 to 1993, bites by Crotalus
durissus ssp accounted for 7.7% of the 65,911 accidents involving snakes
in which the genus was known or suspected, with a lethality rate of
1.9%, the highest among the genera of venomous Brazilian snakes5.
These accidents have been described mainly in the states of Minas Gerais
and São Paulo (southeastern Brazil), with C. d. terrificus being the
subspecies most frequently implicated1,8,14. Acute renal failure and acute
respiratory failure are the main causes of death in such envenomations3,20.
The venom of C. d. terrificus contains a variety of toxic proteins,
including crotoxin, crotamine, gyroxin, convulxin and a thrombin-like
enzyme15,17,25. Clinically, the most important of these toxins is crotoxin,
which accounts for at least 50% of the venom protein17. Crotoxin is a
potent presynaptic neurotoxin that acts at the neuromuscular junction to
produce neuromuscular blockade and progressive flaccid paralysis (acute
myasthenic syndrome) of variable intensity17,25. Crotoxin may also induce
severe and selective skeletal muscle injury (rhabdomyolysis) in which
only muscles or muscle regions composed of oxidative type I and IIA
fibers are injured10,17,22. The thrombin-like component of C. d. terrificus
venom can cause hypofibrinogenemia or complete fibrinogen
consumption, resulting in partial or complete blood incoagulability in
envenomed patients15,21. A platelet-aggregating factor has also been
isolated from the venoms of C. d. terrificus and C. d. cascavella15.
However, thrombocytopenia has rarely been detected in envenomed
patients21, although this may reflect the relatively small amount of this
component present in the venom15.
Twenty-one percent of snakebites in Brazil occur in patients under
15 years old4. However, only two studies, published by the same authors,
have described the clinical and laboratory aspects of C. d. terrificus
snakebites in a case series of children (10 to 21 patients) in Brazil9,11.
The present report describes the clinical and some laboratory aspects of
bites caused by C. durissus ssp in 31 children less than 15 y old admitted
to the University Hospital of the State University of Campinas
(UNICAMP) in Campinas, São Paulo state.
PATIENTS AND METHODS
The hospital records of 31 patients admitted to the University Hospital
at UNICAMP were collected prospectively over a 16-year period
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(January, 1984 - March, 1999). Six of these 31 patients had received
initial treatment at other centers before transferred to UNICAMP. The
diagnosis was based on the envenoming syndrome and/or snake
identification.
In all cases, information on the time, day and month of bite, as well
as the patient’s age, sex and geographic residence were recorded. The
place where the bite occurred, as well as the anatomical site of the bite,
the application of first aid, the time elapsed between the bite and medical
treatment, the local and systemic signs and symptoms observed, the
severity of envenoming, the treatment administered upon admission
[including medication prior to antivenom (AV) infusion], the number of
vials of AV and any associated reaction to AV, and the subsequent outcome
of the cases were noted.
Following posterior review, the accidents were classified according
to the Brazilian Ministry of Health recommendations5: mild- delayed
mild neurotoxic signs and symptoms without myalgia or urine color
alteration; moderate- mild neurotoxic signs and symptoms observed early
after the bite, possibly associated with light myalgia and slightly dark
urine; severe- acute myasthenic syndrome is evident (palpebral ptosis
and weakness) associated with generalized myalgia and dark brown urine.
Oliguria and anuria may be also present in severe cases. Blood coagulation
disorders may be observed in mild, moderate or severe envenoming.
The accidents were also classified as dry-bites when the children did not
present local or systemic clinical manifestations and showed normal
laboratory tests19,24.
The whole blood clotting time5 and/or prothrombin, thrombin and
activated partial thromboplastin times (using commercial reagents kits)
were determined. A whole blood clotting time between 10 min and 30
min was considered prolonged, whereas a time greater than 30 min
represented incoagulable blood (Rosenfeld, G., 1965, apud5). Total blood
creatine kinase (CK) and lactate dehydrogenase (LDH) activities were
also determined using commercial kits. These results were expressed as
the ratio between the encountered value and the upper limit of the
reference value. Myoglobinuria was determined using the latex
agglutination test (Rapitex®, Behring Laboratories, Germany).
When required, the patients received polyspecific, hyperimmune
equine crotalic AV (10 ml/vial, produced by the Instituto Butantan, São
Paulo, SP; the Fundação Ezequiel Dias, Belo-Horizonte, MG; and the
Instituto Vital Brazil, Rio de Janeiro, RJ, Brazil) i.v. over 20-30 min.
One milliliter of AV, which consists mainly of the F(ab’)2 fragment of
immunoglobulins, neutralizes 1.5 mg of C. d. terrificus venom in a
standard mouse assay. From November, 1989, to March, 1999, all patients
who received crotalic AV only at UNICAMP (N = 16) were pretreated
with histamine H1 and H2 antagonists such as clorpheniramine (0.05
mg/kg), cimetidine (10 mg/kg) or ranitidine (3 mg/kg) i.v. or i.m., and
hydrocortisone i.v. (10 mg/kg) at least 15 min before AV infusion5,6,12.
A database was constructed to obtain the frequency distribution of
the variables studied, using the software program Epi-Info version 6.04
(Centers for Disease Control, Atlanta, GA, USA). Differences between
the frequencies of some variables were compared using Fisher’s exact
probability test. The significance of the differences in the total CK and
LDH levels between the groups classified as moderate and severe was
evaluated using the Mann-Whitney U test. Some of these results (first
measurement of CK and LDH) are shown as box and whisker plots. In
each plot, the upper and lower short horizontal lines indicate the
maximum and minimum values observed, respectively. The median, first
and third quartiles of the CK and LDH values of each group correspond
to the intermediate, lower and upper horizontal lines used to construct
each rectangle, respectively. A p value < 0.05 was considered to indicate
significance.
RESULTS
The offending snake was brought for identification to the level of
species in ten of the 31 cases.
The patients’ age ranged from 1 y to 14 y (median = 8 y, mean + SD
= 8.7 + 3.4 y). Most accidents involved male victims (25/31) and occurred
between 13:00 h and 19:00 h (17/31), from November to April (24/31),
in rural areas, including around the home.
Lower limbs were the most commonly bitten (N = 28/31; feet, N =
12; legs, N = 9 and ankles, N = 7). A tourniquet was used in six of the 31
cases.
Table 1 summarizes the main clinical features in this case series.
Most of the patients showed systemic manifestations of neuromuscular
involvement. Local signs and symptoms, mainly slight edema and
erythema, were also observed. No deaths were recorded.
Myoglobinuria was detected in most children studied (N = 14/15;
moderate, 3/3 and severe, 11/12). The sequential measurements of total
CK and LDH levels (up to 114 h post-bite) in children classified as
moderate and severe envenoming are shown in Fig. 1. These data suggest
varying degrees of skeletal muscle damage in all children with a
significant difference in the CK and LDH levels between these two groups
of patients, either for the first measurement [Fig. 2A (CK), p = 0.04;
Fig. 2B (LDH), p = 0.03; Mann-Whitney U test] or for sequential
measurements (CK, p < 0.001 and LDH, p < 0.001; Mann-Whitney U
test). No skeletal muscle biopsy was performed.
Blood coagulation disorders upon hospital admission were observed
in 20 of the 25 children who received AV only at UNICAMP
(incoagulable blood in 17/25, Table 2). All children with severe
envenoming showed coagulation disorders. Most of these children (19/
25) received AV less than 6 h after the bite. Patients admitted less than
and more than 6 h after the bite showed the same risk of developing
severe envenoming [severe (N = 12) vs mild and moderate (N = 13)
cases; Fisher’s exact test, p = 1, Table 2]. No children of the first group
(< 6 h) showed severe complications whereas 3/6 children admitted more
than 6 h post-bite developed acute renal failure, with two requiring
dialysis (Table 1).
AV early reactions were observed in 20 of the 25 children who
received AV only at UNICAMP, and were less frequent in children
pretreated with histamine H1 and H2 antagonists and hydrocortisone.
However, there was no significant difference in the frequency of AV
early reactions between pretreated and non-pretreated groups (Fisher’s
exact test, p = 0.12, Table 2). A similar frequency of AV early reactions
per individual was observed in both groups, with most of these reactions
being considered mild (Table 3). Five patients (three pretreated with the
above scheme) developed severe early reactions with dyspnea (N = 4),
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Table 1
The main features of bites according to the severity of envenoming in 31
children bitten by C. durissus ssp
Features Dry-bite Mild Moderate Severe Total
N = 1 N = 3 N = 9 N = 18 N = 31
Bite site
Edema 0 2 7 11 20
Erythema 1 0 4 14 19
Pain 0 2 4 9 15
Paresthesia 0 1 0 2 3
Systemic manifestations
Palpebral ptosis 0 0 9 18 27
Prostration 0 0 7 16 23
Myalgia 0 0 7 16 23
Tachycardia 0 0 7 13 20
Weakness 0 1 6 13 20
Dark urine 0 1 2 14 17
Mydriasis 0 0 5 12 17
Vomiting 0 0 4 9 13
Diplopia 0 0 3 8 11
Superficial breathing 0 0 0 6 6
Diaphoresis 0 0 1 4 5
Anisocoria 0 0 0 2 2
Myosis 0 0 0 1 1
Bleeding 0 0 0 1 1
Tetany 0 0 0 1 1
Complications
Acute renal failure 0 0 0 3 3
Local infection (cellulitis) 0 0 0 2 2
AV* before UNICAMP 0 0 0 3 3
AV before and 0 0 0 3 3
at UNICAMP
AV only at UNICAMP 1 3 9 12 25
*AV = antivenom
Fig. 1 - Scatter plot of the sequential results of total CK (A) and LDH (B) enzyme activities*
in 27 children classified as moderate (N = 9) and severe (N = 18) envenoming up to 114 h
post-bite by C. durissus ssp.
*The individual results are presented as the ratio between the encountered value and the
upper limit of the reference value. CK = creatine kinase, LDH = lactate dehydrogenase.
There was a statistical difference between moderate and severe cases based on the sequential
results for total CK and LDH (CK, p < 0.001; LDH, p < 0.001; Mann-Whitney U test). There
was no statistical difference between moderate and severe cases when the interval between
the bite and the time of sample collection for analysis were compared (CK, p = 0.36; LDH, p
= 0.18; Mann-Whitney U test).
bradycardia (N = 3), arterial hypotension (N = 3), wheezes (N = 2) and
stridor (N = 1) (Table 4). No late AV reactions were observed.
DISCUSSION
In most of the cases reported here, diagnosis was based on the
anamnesis plus the clinical manifestations and laboratory tests which
suggested envenoming by C. durissus ssp. All the bites were probably
caused by C. d. terrificus, the only subspecies routinely identified in the
geographical area studied3,8,14.
That accidents were more common from November to April generally
reflected the influence of seasonal factors such as an increase in
temperature and humidity and in human activity in rural areas8,14. In
contrast to the Brazilian Ministry of Health data5, 30% of venomous
snakebites in children admitted to our service from 1984 to 1999 were
caused by C. durissus ssp. A similar frequency was reported by CUPO
et al. in Ribeirão Preto, SP11.
The high frequency of bites involving the legs (N = 9/31) may be
related to accidents caused by adult snakes14. Patients bitten in the legs
had a higher risk of developing severe envenoming [severe (N = 8/18)
vs non-severe cases (“dry-bite”, mild and moderate, N = 1/13), Fisher’s
exact test, p = 0.04]. Although six patients had used tourniquets, no
benefit of this procedure has been demonstrated in patients bitten by C.
durissus ssp in Brazil1.
One case classified as a “dry-bite”, in which the snake was brought
for identification, was admitted 4 h after the bite and received AV. Such
patients should be correctly diagnosed and observed for at least 12-24 h
but should not be treated unnecessarily with sometimes hazardous AV19,24,
like the case above.
As reported elsewhere9,11, most of the children were classified as
having severe envenoming and showed clinical manifestations of
neuromuscular involvement plus biochemical evidence of skeletal muscle
damage within 6 h after the bite. The severity classification used was
essentially based on clinical aspects5. In addition, the present results
indicated a significant association between severity and blood enzyme
levels (total CK and LDH, Fig. 1 and 2). As also observed by CUPO et
al.10, increased levels of both CK and LDH were observed early on, with
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Table 3
Antivenom early reactions in 20 children bitten by C. durissus ssp snakes who
received antivenom only at UNICAMP. Eleven patients were pretreated with
histamine H1 and H2 antagonists and hydrocortisone
Early reaction Pretreated Not pretreated Total
N = 11 N = 9 N = 20
Urticaria 7 6 13
Tremors 3 3 6
Cardiac arrhythmias 3 1 4
Dyspnea 2 2 4
Cough 2 1 3
Vomiting 1 2 3
Morbiliform rash 1 2 3
Hypotension 1 2 3
Bradycardia 2 1 3
Flushing 2 0 2
Abdominal pain 1 1 2
Wheezes 2 0 2
Palpebral edema 2 0 2
Tachycardia 1 1 2
Stridor 1 0 1
Facial edema 1 0 1
Others 2 1 3
TOTAL 34 23 57
ER* per individual 3.1 2.6 2.9
*ER = early reaction (mean)
Table 2
The interval between bite and hospital admission and the frequency of blood
coagulation disorders and antivenom early reactions (with and without
pretreatment) according to the severity of envenoming in 25 children bitten
by C. durissus ssp who received antivenom only at UNICAMP
Features Dry-bite Mild Moderate Severe Total
N = 1 N = 3 N = 9 N = 12 N = 25
Admission (h after bite)
 < 3 h - 3 5 4 12
 3 – 6 h 1 - 1 5 7
 > 6 h - - 3 3 6
Coagulation
 Not determined - 1 0 0 1
 Normal 1 1 2 0 4
 Altered - 1 7 12 20
 (incoagulable) (0) (6) (11) (17)
Crotalic AV* (ml) 60 90-100 70-200 100-200
 Median (ml) 60 100 100 200 170
 Early reactions 1/1 2/3 8/9 9/12 20/25
 (with pretreatment)† - (0/1) (5/6) (6/9) (11/16)
 (without pretreatment) (1/1) (2/2) (3/3) (3/3) (9/9)
*AV= antivenom; † = Pretreatment with histamine H1 and H2 antagonists and
hydrocortisone.
Fig. 2 - Comparison of the results of the first measurement of total CK (A) and LDH (B) activities
between moderate and severe cases of envenoming in children bitten by C. durissus ssp.
CK = creatine kinase, LDH = lactate dehydrogenase. The data are shown as box and whisker
plots. *p < 0.05 for the comparisons indicated at the top of the panel (Mann-Whitney U test).
The individual results represent the ratio between the encountered value and the upper limit
of the reference value. There was no statistical difference between moderate and severe cases
when the interval between the bite and the time of sample collection for analysis were compared
(CK, p = 0.46; LDH, p = 0.61; Mann-Whitney U test).
a more rapid rise and decline in CK compared to LDH (Fig. 1). Although
not shown in the results, 8 out of 20 patients developed hypocalcemia,
only one of which was symptomatic (tetany, Table 1). Hypocalcemia
should always be monitored in patients with intense rhabdomyolysis
since it is a common complication in this situation3,11.
Although only one patient presented systemic bleeding, the frequency
of blood coagulation disorders among the patients who received AV only
at UNICAMP (N = 20/25) was greater than observed after Bothrops spp
snakebites in children (N = 34/56) during the same period7. Systemic
bleeding is rarely observed after bites by C. durissus ssp14,21, in contrast to
accidents caused by Bothrops spp7, probably because of the lack of
hemorrhagic activity in C. d. terrificus venom15. The high frequency of
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blood coagulation disorders in children bitten by C. durissus ssp may
reflect the severity of envenoming in this age group, with possible additional
effects secondary to the powerful myotoxic action of the venom21.
Soft-tissue infection has been frequently observed after severe
Bothrops spp snakebites in children7. Although anaerobes and Gram
negative bacteria have been isolated from the venom and oral cavities of
South American rattlesnakes17, local infection following envenoming
are rare, perhaps because C. durissus terrificus venom causes only minor
local tissue damage17.
Although patients admitted less than and more than 6 h after the bite
showed the same risk of developing severe envenoming, no severe
complications were observed in the first group (< 6 h). On the other
hand, all of the children who developed acute renal failure (N = 3) received
AV more than 9 h after the bite. Acute renal failure is the main
complication and cause of death after C. durissus ssp snakebites3,5,9-
11,14,20,23
, and an increased risk of renal failure has been correlated with
the interval between the bite and receiving medical help23. These results
suggest a greater efficacy for AV administered soon after a bite in
association with other supportive measures (intravenous fluids, sodium
bicarbonate and diuretics such as furosemide or mannitol) to prevent
acute tubular necrosis secondary to rhabdomyolysis. This approach
should provide a good hydration with a diuresis higher than 2 ml/kg/h
and a urinary pH of 7.0-8.05,11.
AV early reactions observed in the present case series (N = 20/25)
were more severe and more frequent than those seen after Bothrops spp
snakebites in children (N = 25/56)7 during the same period. This could be
related partly to the amount of crotalic AV infused (median = 170 ml)
compared with bothropic AV (median = 60 ml), and with the type of AV5,6,26.
Considering these AV reactions, recombinant antibodies against crotoxin
from C. d. terrificus venom may represent an interesting therapeutic
alternative as a safer AV2, although this needs to be confirmed in clinical
trials. However, the large scale manufacturing of these products tends to
be very expensive. Although a higher frequency of AV early reactions was
observed in patients not pretreated with histamine H1 and H2 antagonists
and hydrocortisone, statistical analysis suggested that such treatment was
not efficient. However, since the present study is not a randomized, placebo-
controlled trial, its methodological limitations preclude conclusions about
the real efficacy of the pretreatment scheme used here. Recent randomized,
double-blind clinical studies have shown a significant reduction in AV
early reactions in patients pretreated with adrenaline s.c. in Sri-Lanka18,
as well as an inability of promethazine i.m. in preventing AV early reactions
in patients who received bothropic AV13.
In conclusion, most accidents caused by C. d. terrificus in children
are severe. The prognosis can be good, as long as the children receive
prompt medical care, including adequate AV prescription and hydration,
as well as correct treatment for the main complications.
RESUMO
Acidentes por serpentes Crotalus durisssus ssp  em crianças em
Campinas, São Paulo, Brasil
De janeiro de 1984 a março de 1999, 31 crianças com menos de 15
anos de idade (1 a 14 anos, mediana = 8 anos) foram admitidas após
terem sido picadas por Crotalus durissus ssp. Uma criança não apresentou
manifestações clínicas de envenenamento, enquanto 3 foram classificadas
como acidente leve, 9 como moderado e 18 como grave. A maioria das
crianças apresentou envolvimento neuromuscular, tais como ptose
palpebral (27/31), mialgia (23/31) e fraqueza (20/31). Alterações
laboratoriais sugerindo rabdomiólise também foram observadas, como
aumento das enzimas séricas CK (28/29) e LDH (25/25) e mioglobinúria
(14/15). As principais manifestações locais observadas foram edema
discreto (20/31) e eritema (19/31). Alterações da coagulação, antes da
administração da soroterapia antiveneno (SAV), foram observadas em
20 das 25 crianças que receberam a SAV exclusivamente em nosso
hospital (sangue incoagulável em 17/25). Reações precoces à SAV foram
observadas em 20 destes 25 casos, em todos os pacientes não pré-tratados
(N = 9) e em 11 dentre os 16 pré-tratados com antagonistas H1 e H2 da
histamina e hidrocortisona. Não foram constatadas diferenças estatísticas
significativas comparando-se a freqüência de reações precoces à SAV
entre os grupos que receberam ou não o pré-tratamento (teste exato de
Fisher, p = 0,12). Pacientes atendidos com menos ou mais de 6 horas
após o acidente apresentaram o mesmo risco quanto a evolução para
casos graves (teste exato de Fisher, p = 1), não se observando
complicações graves no 1o grupo (< 6 h), enquanto 3/6 admitidos mais
de 6 horas após a picada evoluíram com insuficiência renal aguda.
Pacientes picados na perna apresentaram um maior risco de desenvolver
acidentes graves (teste exato de Fisher, p = 0,04). Houve uma associação
significativa entre os níveis séricos das enzimas CK e LDH total e
gravidade (teste U de Mann-Whitney, CK, p < 0,001; LDH, p < 0,001).
Nenhum óbito foi registrado.
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